JP2014513036A5 - - Google Patents

Download PDF

Info

Publication number
JP2014513036A5
JP2014513036A5 JP2013536737A JP2013536737A JP2014513036A5 JP 2014513036 A5 JP2014513036 A5 JP 2014513036A5 JP 2013536737 A JP2013536737 A JP 2013536737A JP 2013536737 A JP2013536737 A JP 2013536737A JP 2014513036 A5 JP2014513036 A5 JP 2014513036A5
Authority
JP
Japan
Prior art keywords
dmf
diisopropylphosphorano
rucl
dimethylformamide
benzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013536737A
Other languages
English (en)
Japanese (ja)
Other versions
JP5945545B2 (ja
JP2014513036A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013536737A priority Critical patent/JP5945545B2/ja
Priority claimed from PCT/JP2012/054337 external-priority patent/WO2012111849A1/en
Publication of JP2014513036A publication Critical patent/JP2014513036A/ja
Publication of JP2014513036A5 publication Critical patent/JP2014513036A5/ja
Application granted granted Critical
Publication of JP5945545B2 publication Critical patent/JP5945545B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013536737A 2011-02-17 2012-02-16 光学活性なジヒドロベンゾフラン誘導体の製造法 Expired - Fee Related JP5945545B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013536737A JP5945545B2 (ja) 2011-02-17 2012-02-16 光学活性なジヒドロベンゾフラン誘導体の製造法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2011032610 2011-02-17
JP2011032610 2011-02-17
PCT/JP2012/054337 WO2012111849A1 (en) 2011-02-17 2012-02-16 Production method of optically active dihydrobenzofuran derivative
JP2013536737A JP5945545B2 (ja) 2011-02-17 2012-02-16 光学活性なジヒドロベンゾフラン誘導体の製造法

Publications (3)

Publication Number Publication Date
JP2014513036A JP2014513036A (ja) 2014-05-29
JP2014513036A5 true JP2014513036A5 (https=) 2015-04-02
JP5945545B2 JP5945545B2 (ja) 2016-07-05

Family

ID=45841559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013536737A Expired - Fee Related JP5945545B2 (ja) 2011-02-17 2012-02-16 光学活性なジヒドロベンゾフラン誘導体の製造法

Country Status (24)

Country Link
US (1) US8952185B2 (https=)
EP (1) EP2675774A1 (https=)
JP (1) JP5945545B2 (https=)
KR (1) KR20140015371A (https=)
CN (1) CN103492348A (https=)
AR (1) AR085252A1 (https=)
AU (1) AU2012218401A1 (https=)
BR (1) BR112013020634A2 (https=)
CA (1) CA2827271A1 (https=)
CL (1) CL2013002356A1 (https=)
CO (1) CO6761376A2 (https=)
CR (1) CR20130407A (https=)
DO (1) DOP2013000188A (https=)
EA (1) EA201391180A1 (https=)
EC (1) ECSP13012855A (https=)
IL (1) IL227879A0 (https=)
MA (1) MA34965B1 (https=)
MX (1) MX2013009526A (https=)
PH (1) PH12013501718A1 (https=)
SG (1) SG192645A1 (https=)
TN (1) TN2013000347A1 (https=)
TW (1) TW201245169A (https=)
UY (1) UY33913A (https=)
WO (1) WO2012111849A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103145663B (zh) * 2013-03-01 2016-03-23 上海高准医药有限公司 (s)-2-(2,3-二氢苯并呋喃-3-基)乙酸衍生物,其制备方法及其在医药上的应用
CN104250239B (zh) * 2013-06-29 2016-09-07 山东轩竹医药科技有限公司 芳香多环羧酸衍生物
CN104370864B (zh) * 2013-08-14 2016-04-13 成都苑东生物制药股份有限公司 一种2-(6-羟基-2,3-二氢苯并呋喃-3-基)乙腈化合物和以该化合物制备tak-875药物的方法
EP3049396B1 (en) * 2013-09-26 2017-11-15 Boehringer Ingelheim International GmbH Process and intermediates for preparing indanyloxydihydrobenzofuranyl acetic acid derivatives as gpr40 agonists
EP3068788A1 (en) 2013-11-14 2016-09-21 Cadila Healthcare Limited Novel heterocyclic compounds
EP3076959B1 (en) 2013-12-04 2018-07-04 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
CN104177320B (zh) * 2014-08-27 2016-03-02 广东东阳光药业有限公司 一种脲取代联苯类化合物及其组合物及用途
BR112017019918B1 (pt) * 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para produzir uma preparação sólida farmacêutica para estabilizar uma preparação sólida farmacêutica
BR112017019920B1 (pt) 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
CN105418563B (zh) * 2015-12-28 2017-11-10 山东大学 Tak‑875类似物及其制备方法与应用
CN107543872B (zh) * 2016-06-29 2022-03-08 南京长澳医药科技有限公司 通过手性高效液相色谱法分离测定甲苯磺酸依度沙班水合物与其异构体杂质的方法
WO2018077699A1 (en) 2016-10-25 2018-05-03 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
US10919859B2 (en) 2017-01-26 2021-02-16 Boehringer Ingelheim International Gmbh Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
CN106977478B (zh) * 2017-04-21 2019-04-09 山东大学 一种2-(6-羟基-2,3-二氢苯并呋喃-3-基)乙酸甲酯的手性拆分方法
CR20200347A (es) 2018-02-13 2020-09-23 Gilead Sciences Inc Inhibidores pd-1/pd-l1
TWI712412B (zh) 2018-04-19 2020-12-11 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
SG11202012425QA (en) 2018-07-13 2021-01-28 Gilead Sciences Inc Pd-1/pd-l1 inhibitors
BR112021001008A2 (pt) 2018-07-30 2021-04-20 Daiichi Sankyo Company, Limited comprimido de fármaco
WO2020086556A1 (en) 2018-10-24 2020-04-30 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
KR20220150270A (ko) 2019-10-07 2022-11-10 칼리오페, 인크. Gpr119 효능제
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
WO2021236617A1 (en) 2020-05-19 2021-11-25 Kallyope, Inc. Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
CN114539168B (zh) * 2020-11-27 2023-11-17 武汉大学 一种合成Piragliatin及其类似物的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1072649C (zh) 1995-09-13 2001-10-10 武田药品工业株式会社 苯并氧杂吖庚因化合物,其生产方法和用途
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
CA2416384A1 (en) 2000-07-17 2003-01-16 Takeda Chemical Industries, Ltd. Sulfone derivatives, their production and use
AU2003278600A1 (en) 2002-11-01 2004-05-25 Takeda Pharmaceutical Company Limited Agent for preventing or treating neuropathy
CA2505322A1 (en) 2002-11-08 2004-05-21 Takeda Pharmaceutical Company Limited Receptor function regulator
US20070004736A1 (en) 2002-11-22 2007-01-04 Keiji Kubo Imidazole derivative, process for producing the same, and use
EP1630152A4 (en) 2003-05-30 2009-09-23 Takeda Pharmaceutical CONDENSED CYCLIC COMPOUND
EP1669352A4 (en) 2003-09-30 2008-12-17 Takeda Pharmaceutical THIAZOLINE DERIVATIVE AND ITS USE
EP1695961A4 (en) 2003-12-17 2007-10-24 Takeda Pharmaceutical UREA DERIVATIVE, METHOD FOR THE PRODUCTION AND THEIR USE
AU2004309271A1 (en) 2003-12-25 2005-07-14 Takeda Pharmaceutical Company Limited 3-(4-benzyloxyphenyl)propanoic acid derivatives
WO2005063725A1 (ja) 2003-12-26 2005-07-14 Takeda Pharmaceutical Company Limited フェニルプロパン酸誘導体
JP4875978B2 (ja) 2004-03-15 2012-02-15 武田薬品工業株式会社 アミノフェニルプロパン酸誘導体
US7517910B2 (en) 2004-03-30 2009-04-14 Takeda Pharmaceutical Company Limited Alkoxyphenylpropanoic acid derivatives
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
GB0428101D0 (en) * 2004-12-23 2005-01-26 Astrazeneca Ab Chemical Processes & Intermediates
US8957070B2 (en) 2005-04-20 2015-02-17 Takeda Pharmaceutical Company Limited Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
US20090054435A1 (en) 2005-07-29 2009-02-26 Hiroshi Imoto Phenoxyalkanoic Acid Compound
EP1916234B1 (en) 2005-07-29 2014-11-12 Takeda Pharmaceutical Company Limited Cyclopropanecarboxylic acid compound
TW200740435A (en) 2005-08-10 2007-11-01 Takeda Pharmaceuticals Co Therapeutic agent for diabetes
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
RS53230B (sr) 2006-06-27 2014-08-29 Takeda Pharmaceutical Company Limited Kondenzovana ciklična jedinjenja kao modulatori gpr40 receptora
US8492405B2 (en) 2006-10-18 2013-07-23 Takeda Pharmaceutical Company Limited Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity
RU2454415C9 (ru) 2006-10-19 2013-02-27 Такеда Фармасьютикал Компани Лимитед Производное индола
EP2128138A1 (en) 2007-01-29 2009-12-02 Takeda Pharmaceutical Company Limited Pyrazole compound
JP2010517935A (ja) 2007-02-09 2010-05-27 武田薬品工業株式会社 Ppar−ガンマのパーシャルアゴニストとしての縮合環化合物
WO2008101197A1 (en) 2007-02-18 2008-08-21 University Of Florida Research Foundation, Inc. Catalysts containing n-heterocyclic carbenes for enantioselective synthesis
JPWO2008136428A1 (ja) 2007-04-27 2010-07-29 武田薬品工業株式会社 含窒素5員複素環化合物
WO2008156757A1 (en) 2007-06-19 2008-12-24 Takeda Pharmaceutical Company Limited Indazole compounds for activating glucokinase
WO2010143733A1 (en) 2009-06-09 2010-12-16 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
JP5129209B2 (ja) 2009-08-03 2013-01-30 ゴールドフラッグ株式会社 ブラジャー及び該ブラジャー付き下着とこれをインナーとしたアウター

Similar Documents

Publication Publication Date Title
JP2014513036A5 (https=)
LTPA2019504I1 (lt) Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
JP2011506530A5 (https=)
JP2013514381A5 (https=)
JP2015504870A5 (https=)
JP2010219032A5 (https=)
JP2011527428A5 (https=)
JP2010538767A5 (https=)
JP2013500200A5 (https=)
JP2011508438A5 (https=)
JP2015518492A5 (https=)
JP2013540702A5 (https=)
JP2011242375A5 (https=)
JP2012250569A5 (https=)
JP2013522131A5 (https=)
JP2012043586A5 (https=)
JP2011246422A5 (https=)
JP2014508179A5 (https=)
JP2014520066A5 (https=)
JP2013506570A5 (https=)
JP2012006888A5 (https=)
JP2014048562A5 (https=)
JP2011249271A5 (https=)
CN301973213S (zh) 椅子(gs-g1795b)
CN302155520S (zh) 水龙头(面盆-0008)